Jaspal Singh, MD, MHS

Articles

Unmet Needs and Future Perspectives in the NSCLC Treatment Landscape

February 21st 2023

Looking to the future, a panel of experts offer closing remarks on promising developments and unmet needs in the treatment of NSCLC.

Neoadjuvant Therapy and Other Emerging Therapies in Early Stage NSCLC

February 14th 2023

Experts discuss the role of neoadjuvant therapy and other emerging therapies in the treatment of early-stage NSCLC.

Treatment Approach for Patients With Stage II-IIIA NSCLC

February 14th 2023

Jaspal Singh, MD, MHS, shares insights on treatment strategies for patients with stage II-IIIA NSCLC.

Patient Profile 2: Former Smoker Diagnosed With NSCLC

February 7th 2023

David H. Harpole Jr, MD, presents a case of a former smoker diagnosed with NSCLC, and David Spigel, MD, offers his initial impressions.

Choosing Appropriate Patients for Surgical Resection in NSCLC

February 7th 2023

An expert panel shares perspectives on how to choose the appropriate patients with non-small cell lung cancer for lung resection.

Therapies Targeting Specific Molecular Alterations in NSCLC

January 31st 2023

A panel of distinguished experts discuss how detection of actionable mutations affect their treatment choices in non-small cell lung cancer.

Adjuvant Therapy in Early Stage NSCLC

January 31st 2023

David Spigel, MD, and David H. Harpole Jr, MD, describe when adjuvant therapy is recommended in early stage NSCLC and discuss data from recent clinical trials of adjuvant therapy.

Treatment Approach for Patients With Stage IB Disease

January 24th 2023

A panel of experts in the treatment of NSCLC discusses how they manage patients with stage IB disease.

Workup and Molecular Testing for a Patient with NSCLC

January 24th 2023

David H. Harpole Jr, MD, a thoracic surgeon, details his workup approach and discussed molecular testing for patients who present with NSCLC.

Patient Profile 1: A 57-Year-Old Woman Diagnosed With NSCLC

January 17th 2023

David Spigel, MD, presents a patient case of a 57-year-old woman with NSCLC, and Jaspal Singh, MD, MHS, discusses his approach to initial evaluation.

Multidisciplinary Care in Non-Small Cell Lung Cancer

January 17th 2023

A panel of experts introduce themselves and explain their approaches to multidisciplinary care in treating non-small cell lung cancer.